Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Mathai

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Psychedelic Medicine (New Rochelle, N.Y.)|December 28, 2023
Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy VolunteersDavid S Mathai, Samantha Hilbert, Nathan D Sepeda, et al.
Journal of Cannabis Research|May 29, 2026
Knowledge, attitudes, and concerns about medical cannabis among U.S. healthcare professionalsLakshmi Kumar, Erin Wang, David S Mathai, et al.
Translational Behavioral Medicine|May 19, 2026
From trials to clinics: investigators' perspectives on translating psychedelic research into clinical careJoshua Mitchell, Logan Neitzke-Spruill, David S Mathai, et al.
JAMA Network Open|January 7, 2026
Reported Safety Practices of Publicly Advertised Psychedelic RetreatsAmy L McGuire, Logan Neitzke-Spruill, Jill O Robinson, et al.
Journal of Child and Adolescent Psychopharmacology|October 19, 2021
Parental Attitudes Toward Use of Ketamine in Adolescent Mood Disorders and SuicidalityDavid S Mathai, Alexis G McCathern, Andrew G Guzick, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|June 24, 2017
Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot StudyDavid S Mathai, Manuela Holst, Christopher Rodgman, et al.
The American Journal on Addictions|September 5, 2019
Use of Guanfacine for Cannabis Use Disorder and Related SymptomologyManuela Holst, David S Mathai, Marguerite M Patel, et al.
Journal of Psychoactive Drugs|February 8, 2025
Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin UseDavid S Mathai, Daniel E Roberts, Sandeep M Nayak, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|September 30, 2025
Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO StudyDavid S Mathai, Jill O Robinson, Kevin Wagner, et al.
Frontiers in Psychiatry|October 5, 2023
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal surveySandeep M Nayak, Hillary Jackson, Nathan D Sepeda, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Psychedelic Medicine (New Rochelle, N.Y.)|December 28, 2023
Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy VolunteersDavid S Mathai, Samantha Hilbert, Nathan D Sepeda, et al.
Journal of Cannabis Research|May 29, 2026
Knowledge, attitudes, and concerns about medical cannabis among U.S. healthcare professionalsLakshmi Kumar, Erin Wang, David S Mathai, et al.
Translational Behavioral Medicine|May 19, 2026
From trials to clinics: investigators' perspectives on translating psychedelic research into clinical careJoshua Mitchell, Logan Neitzke-Spruill, David S Mathai, et al.
JAMA Network Open|January 7, 2026
Reported Safety Practices of Publicly Advertised Psychedelic RetreatsAmy L McGuire, Logan Neitzke-Spruill, Jill O Robinson, et al.
Journal of Child and Adolescent Psychopharmacology|October 19, 2021
Parental Attitudes Toward Use of Ketamine in Adolescent Mood Disorders and SuicidalityDavid S Mathai, Alexis G McCathern, Andrew G Guzick, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|June 24, 2017
Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot StudyDavid S Mathai, Manuela Holst, Christopher Rodgman, et al.
The American Journal on Addictions|September 5, 2019
Use of Guanfacine for Cannabis Use Disorder and Related SymptomologyManuela Holst, David S Mathai, Marguerite M Patel, et al.
Journal of Psychoactive Drugs|February 8, 2025
Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin UseDavid S Mathai, Daniel E Roberts, Sandeep M Nayak, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|September 30, 2025
Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO StudyDavid S Mathai, Jill O Robinson, Kevin Wagner, et al.
Frontiers in Psychiatry|October 5, 2023
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal surveySandeep M Nayak, Hillary Jackson, Nathan D Sepeda, et al.
Pageof 3